HF
PDSB icon

HRT Financial’s PDS Biotechnology PDSB Stock Holding History

HRT Financial’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-38,107
Closed -$111K – 2956
2024
Q2 		$111K Buy
+38,107
New +$122K ﹤0.01% 1748
2023
Q2 		– Sell
-88,385
Closed -$543K – 3065
2023
Q1 		$543K Buy
+88,385
New +$723K 0.01% 1310
2022
Q1 		– Sell
-34,786
Closed -$281K – 3665
2021
Q4 		$281K Buy
+34,786
New +$374K ﹤0.01% 2314

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HRT Financial's PDSB Position: Q3 2024 in Review

HRT Financial sold out of PDS Biotechnology (PDSB) in Q3 2024, closing a stake of 38,107 shares — an estimated $111K sold.

HRT Financial first reported a position in PDSB in Q4 2021 and held it in 3 quarters. The position peaked at $543K in Q1 2023. 57 funds tracked by Wall St. Rank hold PDSB as of Q3 2024.

  • HRT Financial reported no remaining PDS Biotechnology position as of Q3 2024 after selling out during the quarter.
  • HRT Financial sold 38,107 PDS Biotechnology shares in Q3 2024, an estimated $111K.
  • HRT Financial first reported a position in PDS Biotechnology in Q4 2021 and held it in 3 quarters.
  • HRT Financial's PDS Biotechnology position peaked at $543K in Q1 2023.
  • 57 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.